Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

BACKGROUND: Optimization of the current dendritic cell (DC) culture protocol in order to promote the therapeutic efficacy of DC-based immunotherapy is warranted. Alternative differentiation of monocyte-derived DCs using granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-1...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Anguille, Sébastien, Smits, Evelien LJM, Cools, Nathalie, Goossens, Herman, Berneman, Zwi N, Van Tendeloo, Vigor FI
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2009
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2807857/
https://ncbi.nlm.nih.gov/pubmed/20021667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-7-109
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak